Synthetic antibody technologies

Current Opinion in Structural Biology

Volumn 24, Issue 1, 2014, Pages 1-9

  Adams, Jarrett J ^a   Sidhu, Sachdev S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; SYNTHETIC ANTIBODY; UNCLASSIFIED DRUG; PHOSPHOPEPTIDE; AFFINITY LABELING; PEPTIDE LIBRARY;

ANTIBODY LIBRARY; ANTIBODY STRUCTURE; CELL COMMUNICATION; CELL SURFACE; CLINICAL RESEARCH; CRYSTALLOGRAPHY; DRUG DESIGN; DRUG SYNTHESIS; GENE AMPLIFICATION; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; MAMMAL CELL; MOLECULAR MIMICRY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; ANTIBODY AFFINITY; ANTIBODY COMBINING SITE; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; BIOTECHNOLOGY; CELL SURFACE DISPLAY; CRYSTAL STRUCTURE; HUMAN; MINIMALIST LIBRARY; NATURAL MIMIC LIBRARY; POSITIONAL FREQUENCY LIBRARY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SYNTHETIC ANTIBODY TECHNOLOGY; AFFINITY LABELING; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CRYSTALLIZATION; DIAGNOSTIC USE; GENE LIBRARY; GENETICS; METABOLISM; PEPTIDE LIBRARY; PROCEDURES; SYNTHESIS;

AFFINITY LABELS; ANIMALS; ANTIBODIES; CRYSTALLIZATION; GENE LIBRARY; HUMANS; MODELS, MOLECULAR; PEPTIDE LIBRARY;

EID: 84889586902     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2013.11.003     Document Type: Review

References (59)

1. Miersch S., Sidhu S.S. Synthetic antibodies: concepts, potential and practical considerations. Methods 2012, 57:486-498.
2. Sidhu S.S., Fellouse F.A. Synthetic therapeutic antibodies. Nat Chem Biol 2006, 2:682-688.
3. Lipovsek D., Pluckthun A. In-vitro protein evolution by ribosome display and mRNA display. J Immunol Methods 2004, 290:51-67.
4. Wittrup K.D. Protein engineering by cell-surface display. Curr Opin Biotechnol 2001, 12:395-399.
5. Smith G.P., Petrenko V.A. Phage display. Chem Rev 1997, 97:391-410.
6. Bradbury A.R., Marks J.D. Antibodies from phage antibody libraries. J Immunol Methods 2004, 290:29-49.
7. Hoogenboom H.R. Selecting and screening recombinant antibody libraries. Nat Biotechnol 2005, 23:1105-1116.
8. Feldhaus M.J., Siegel R.W., Opresko L.K., Coleman J.R., Feldhaus J.M., Yeung Y.A., Cochran J.R., Heinzelman P., Colby D., Swers J., et al. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nat Biotechnol 2003, 21:163-170.
9. Bowers P.M., Horlick R.A., Kehry M.R., Neben T.Y., Tomlinson G.L., Altobell L., Zhang X., Macomber J.L., Krapf I.P., Wu B.F., et al. Mammalian cell display for the discovery and optimization of antibody therapeutics. Methods 2013.
10. Bowley D.R., Jones T.M., Burton D.R., Lerner R.A. Libraries against libraries for combinatorial selection of replicating antigen-antibody pairs. Proc Natl Acad Sci U S A 2009, 106:1380-1385.
11. Bowley D.R., Labrijn A.F., Zwick M.B., Burton D.R. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage. Protein Eng Des Sel 2007, 20:81-90.
12. Burton D.R., Barbas C.F., Persson M.A., Koenig S., Chanock R.M., Lerner R.A. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci U S A 1991, 88:10134-10137.
13. Walker L.M., Bowley D.R., Burton D.R. Efficient recovery of high-affinity antibodies from a single-chain Fab yeast display library. J Mol Biol 2009, 389:365-375.
14. Bostrom J., Yu S.F., Kan D., Appleton B.A., Lee C.V., Billeci K., Man W., Peale F., Ross S., Wiesmann C., et al. Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site. Science 2009, 323:1610-1614.
15. Hoet R.M., Cohen E.H., Kent R.B., Rookey K., Schoonbroodt S., Hogan S., Rem L., Frans N., Daukandt M., Pieters H., et al. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. Nat Biotechnol 2005, 23:344-348.
16. Giang E., Dorner M., Prentoe J.C., Dreux M., Evans M.J., Bukh J., Rice C.M., Ploss A., Burton D.R., Law M. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc Natl Acad Sci U S A 2012, 109:6205-6210.
17. Law M., Maruyama T., Lewis J., Giang E., Tarr A.W., Stamataki Z., Gastaminza P., Chisari F.V., Jones I.M., Fox R.I., et al. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat Med 2008, 14:25-27.
18. Beerli R.R., Rader C. Mining human antibody repertoires. mAbs 2010, 2.
19. Glanville J., Zhai W., Berka J., Telman D., Huerta G., Mehta G.R., Ni I., Mei L., Sundar P.D., Day G.M., et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc Natl Acad Sci U S A 2009, 106:20216-20221.
20. Boyd S.D., Marshall E.L., Merker J.D., Maniar J.M., Zhang L.N., Sahaf B., Jones C.D., Simen B.B., Hanczaruk B., Nguyen K.D., et al. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci Translat Med 2009, 1:12ra23.
21. Virnekas B., Ge L., Pluckthun A., Schneider K.C., Wellnhofer G., Moroney S.E. Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis. Nucleic Acids Res 1994, 22:5600-5607.
22. Rothe C., Urlinger S., Lohning C., Prassler J., Stark Y., Jager U., Hubner B., Bardroff M., Pradel I., Boss M., et al. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. J Mol Biol 2008, 376:1182-1200.
23. Prassler J., Thiel S., Pracht C., Polzer A., Peters S., Bauer M., Norenberg S., Stark Y., Kolln J., Popp A., et al. HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems. J Mol Biol 2011, 413:261-278.
24. Zhai W., Glanville J., Fuhrmann M., Mei L., Ni I., Sundar P.D., Van Blarcom T., Abdiche Y., Lindquist K., Strohner R., et al. Synthetic antibodies designed on natural sequence landscapes. J Mol Biol 2011, 412:55-71.
25. Fisher R.D., Ultsch M., Lingel A., Schaefer G., Shao L., Birtalan S., Sidhu S.S., Eigenbrot C. Structure of the complex between HER2 and an antibody paratope formed by side chains from tryptophan and serine. J Mol Biol 2010, 402:217-229.
26. Birtalan S., Fisher R.D., Sidhu S.S. The functional capacity of the natural amino acids for molecular recognition. Mol Biosyst 2010, 6:1186-1194.
27. Koldobskaya Y., Duguid E.M., Shechner D.M., Suslov N.B., Ye J., Sidhu S.S., Bartel D.P., Koide S., Kossiakoff A.A., Piccirilli J.A. A portable RNA sequence whose recognition by a synthetic antibody facilitates structural determination. Nat Struct Mol Biol 2011, 18:100-106.
28. Larman H.B., Xu G.J., Pavlova N.N., Elledge S.J. Construction of a rationally designed antibody platform for sequencing-assisted selection. Proc Natl Acad Sci U S A 2012, 109:18523-18528.
29. Fellouse F.A., Barthelemy P.A., Kelley R.F., Sidhu S.S. Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code. J Mol Biol 2006, 357:100-114.
30. Fellouse F.A., Li B., Compaan D.M., Peden A.A., Hymowitz S.G., Sidhu S.S. Molecular recognition by a binary code. J Mol Biol 2005, 348:1153-1162.
31. Fellouse F.A., Wiesmann C., Sidhu S.S. Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc Natl Acad Sci U S A 2004, 101:12467-12472.
32. Miller K.R., Koide A., Leung B., Fitzsimmons J., Yoder B., Yuan H., Jay M., Sidhu S.S., Koide S., Collins E.J. T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment. PloS One 2012, 7:e43746.
33. Fellouse F.A., Esaki K., Birtalan S., Raptis D., Cancasci V.J., Koide A., Jhurani P., Vasser M., Wiesmann C., Kossiakoff A.A., et al. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J Mol Biol 2007, 373:924-940.
34. Persson H., Ye W., Wernimont A., Adams J.J., Koide A., Koide S., Lam R., Sidhu S.S. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies. J Mol Biol 2013, 425:803-811.
35. Mahon C.M., Lambert M.A., Glanville J., Wade J.M., Fennell B.J., Krebs M.R., Armellino D., Yang S., Liu X., O'Sullivan C.M., et al. Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potential. J Mol Biol 2013, 425:1712-1730.
36. Bowers P.M., Horlick R.A., Neben T.Y., Toobian R.M., Tomlinson G.L., Dalton J.L., Jones H.A., Chen A., Altobell L., Zhang X., et al. Coupling mammalian cell surface display with somatic hypermutation for the discovery and maturation of human antibodies. Proc Natl Acad Sci U S A 2011, 108:20455-20460.
37. Horlick R.A., Macomber J.L., Bowers P.M., Neben T.Y., Tomlinson G.L., Krapf I.P., Dalton J.L., Verdino P., King D.J. Simultaneous surface display and secretion of proteins from Mammalian cells facilitate efficient in vitro selection and maturation of antibodies. J Biol Chem 2013, 288:19861-19869.
38. King D.J., Bowers P.M., Kehry M.R., Horlick R.A. Mammalian cell display and somatic hypermutation in vitro for human antibody discovery. Curr Drug Discov Technol 2013.
39. McConnell A.D., Do M., Neben T.Y., Spasojevic V., MacLaren J., Chen A.P., Altobell L., Macomber J.L., Berkebile A.D., Horlick R.A., et al. High affinity humanized antibodies without making hybridomas; immunization paired with mammalian cell display and in vitro somatic hypermutation. PloS One 2012, 7:e49458.
40. Xie J., Zhang H., Yea K., Lerner R.A. Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells. Proc Natl Acad Sci U S A 2013, 110:8099-8104.
41. Yea K., Zhang H., Xie J., Jones T.M., Yang G., Song B.D., Lerner R.A. Converting stem cells to dendritic cells by agonist antibodies from unbiased morphogenic selections. Proc Natl Acad Sci U S A 2013.
42. Zhang H., Wilson I.A., Lerner R.A. Selection of antibodies that regulate phenotype from intracellular combinatorial antibody libraries. Proc Natl Acad Sci U S A 2012, 109:15728-15733.
43. Zhang H., Yea K., Xie J., Ruiz D., Wilson I.A., Lerner R.A. Selecting agonists from single cells infected with combinatorial antibody libraries. Chem Biol 2013, 20:734-741.
44. Tereshko V., Uysal S., Koide A., Margalef K., Koide S., Kossiakoff A.A. Toward chaperone-assisted crystallography: protein engineering enhancement of crystal packing and X-ray phasing capabilities of a camelid single-domain antibody (VHH) scaffold. Protein Sci 2008, 17:1175-1187.
45. Ye J.D., Tereshko V., Frederiksen J.K., Koide A., Fellouse F.A., Sidhu S.S., Koide S., Kossiakoff A.A., Piccirilli J.A. Synthetic antibodies for specific recognition and crystallization of structured RNA. Proc Natl Acad Sci U S A 2008, 105:82-87.
46. Uysal S., Cuello L.G., Cortes D.M., Koide S., Kossiakoff A.A., Perozo E. Mechanism of activation gating in the full-length KcsA K+ channel. Proc Natl Acad Sci U S A 2011, 108:11896-11899.
47. Uysal S., Vasquez V., Tereshko V., Esaki K., Fellouse F.A., Sidhu S.S., Koide S., Perozo E., Kossiakoff A. Crystal structure of full-length KcsA in its closed conformation. Proc Natl Acad Sci U S A 2009, 106:6644-6649.
48. Rizk S.S., Paduch M., Heithaus J.H., Duguid E.M., Sandstrom A., Kossiakoff A.A. Allosteric control of ligand-binding affinity using engineered conformation-specific effector proteins. Nat Struct Mol Biol 2011, 18:437-442.
49. Shukla A.K., Manglik A., Kruse A.C., Xiao K., Reis R.I., Tseng W.C., Staus D.P., Hilger D., Uysal S., Huang L.Y., et al. Structure of active beta-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature 2013, 497:137-141.
50. Ahn E.R., Vogel C.L. Dual HER2-targeted approaches in HER2-positive breast cancer. Breast Cancer Res Treat 2012, 131:371-383.
51. Cho H.S., Mason K., Ramyar K.X., Stanley A.M., Gabelli S.B., Denney D.W., Leahy D.J. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 2003, 421:756-760.
52. Franklin M.C., Carey K.D., Vajdos F.F., Leahy D.J., de Vos A.M., Sliwkowski M.X. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell 2004, 5:317-328.
53. Katschke K.J., Stawicki S., Yin J., Steffek M., Xi H., Sturgeon L., Hass P.E., Loyet K.M., Deforge L., Wu Y., et al. Structural and functional analysis of a C3b-specific antibody that selectively inhibits the alternative pathway of complement. J Biol Chem 2009, 284:10473-10479.
54. Eigenbrot C., Fuh G. Two-in-one antibodies with dual action Fabs. Curr Opin Chem Biol 2013, 17:400-405.
55. Schaefer G., Haber L., Crocker L.M., Shia S., Shao L., Dowbenko D., Totpal K., Wong A., Lee C.V., Stawicki S., et al. A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies. Cancer Cell 2011, 20:472-486.
56. May C., Sapra P., Gerber H.P. Advances in bispecific biotherapeutics for the treatment of cancer. Biochem Pharmacol 2012, 84:1105-1112.
57. Koerber J.T., Thomsen N.D., Hannigan B.T., Degrado W.F., Wells J.A. Nature-inspired design of motif-specific antibody scaffolds. Nat Biotechnol 2013.
58. Lefranc M.P., Pommie C., Ruiz M., Giudicelli V., Foulquier E., Truong L., Thouvenin-Contet V., Lefranc G. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol 2003, 27:55-77.
59. Landry R.C., Klimowicz A.C., Lavictoire S.J., Borisova S., Kottachchi D.T., Lorimer I.A., Evans S.V. Antibody recognition of a conformational epitope in a peptide antigen: Fv-peptide complex of an antibody fragment specific for the mutant EGF receptor, EGFRvIII. J Mol Biol 2001, 308:883-893.